Phio Pharmaceuticals Corp. (PHIO) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$12.77M2012: -$12.97M2013: -$20.95M2014: -$8.83M2015: -$10.24M2016: -$9.02M2017: -$14.06M2018: -$7.36M2019: -$8.99M2020: -$8.79M2021: -$13.51M2022: -$11.46M2023: -$10.82M2024: -$7.39M2025: -$9.22M-$9.22M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$9.22M-24.8%
2024-$7.39M+31.8%
2023-$10.82M+5.6%
2022-$11.46M+15.2%
2021-$13.51M-53.7%
2020-$8.79M+2.2%
2019-$8.99M-22.0%
2018-$7.36M+47.6%
2017-$14.06M-56.0%
2016-$9.02M+11.9%
2015-$10.24M-16.0%
2014-$8.83M+57.9%
2013-$20.95M-61.5%
2012-$12.97M-1.6%
2011-$12.77M